Prophylaxis

EMA recommends approval of Truvada as HIV pre-exposure prophylaxis

The first drug for HIV pre-exposure prophylaxis has been recommended for approval across the EU.…

Bone drug could help prevent breast cancer in BRCA1 carriers

Blocking RANK ligand with denosumab reduced proliferation of breast cells from women at high genetic risk of breast cancer.…

Injected antibodies provide long-term protection against HIV

 Trial results show extended protection against HIV in monkeys treated with monoclonal antibodies.…

Losmapimod fails to prevent cardiovascular recurrences after heart attack

Patients treated with losmapimod are just as likely as placebo-treated patients to have a major cardiovascular event, study finds.…

NHS England explains decision not to fund HIV pre-exposure prophylaxis

NHS England has announced that it will not fund HIV prevention drug Truvada (emtricitabine and tenofovir disoproxil fumarate), despite evidence that it dramatically reduces transmission of the virus.…

Flawed decision from NHS England on pre-exposure prophylaxis (PrEP) for HIV prevention

Like the countless people affected by HIV in the UK, we are angry and confused by the decision of NHS England to halt its work to ensure that pre-exposure prophylaxis (PrEP; (emtricitabine/tenofovir, marketed as Truvada), which drastically reduces the chance of infection with HIV, is available on th…

High-risk women need more frequent doses of HIV drugs

Researchers say more frequent pre-exposure prophylaxis is required to protect women from HIV.…

Dapivirine vaginal ring reduces HIV infection rates in women

A ring placed in the vagina that continuously releases experimental antiretroviral drug dapivirine reduced the risk of HIV infection in African women by 27%, according to researchers.…

HIV resistance to tenofovir surprisingly common

International study finds high proportion of HIV patients were resistant to cART drug tenofovir.…

On-demand prophylaxis protects against HIV infection in at-risk men

Randomised trial shows pre-exposure prophylaxis reduced the risk of HIV transmission by 86%.…